LEXX — Lexaria Bioscience Share News
0.000.00%
Last trade - 00:00- $6.49m
- $2.48m
- $0.71m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:07 PM
NASDAQ RESUMED AT 10:04 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:59 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Lexaria Bioscience Corp Authorizes 1-For-15 Reverse Stock Split - SEC Filing
Lexaria Bioscience Corp expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing
Lexaria Bioscience to begin oral weight‑loss drug study; shares up
Brief: Lexaria Bioscience enters securities purchase agreement with investors - SEC filing
Brief: Lexaria Bioscience Corp - On Sept 19, Terminated Capital On Demand Sales Agreement - SEC Filing
Lexaria Bioscience Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Lexaria Bioscience Enters Change Order To Terms Of Its Project Agreement With Novotech
Lexaria Bioscience Corp reports results for the quarter ended February 28 - Earnings Summary
Lexaria Bioscience Corp expected to post a loss of 15 cents a share - Earnings Preview
Brief: Lexaria Bioscience Corp Files For Mixed Shelf Of Up To $50 Million - SEC Filing